Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines

International Journal of Oncology

Volumn 37, Issue 3, 2010, Pages 737-743

  Chen, Weikai ^a,b   Leiter, Amanda ^b   Dong, Yin ^b   Meiring, Muriel ^a   Louw, Vernon J ^d   Koeffler, H Phillip ^b,c  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CSI   (Singapore)

^d UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

Cell cycle; Cisplatin; Cucurbitacin B; Cutaneous squamous cell carcinoma

Indexed keywords

CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 2; CISPLATIN; CUCURBITACIN; CUCURBITACIN B; CYCLIN B1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MIGRATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CUTANEOUS SQUAMOUS CELL CARCINOMA; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PSEUDOPODIUM; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MEMBRANE; CISPLATIN; DRUG SYNERGISM; HUMANS; SKIN NEOPLASMS; TRITERPENES;

EID: 77956532375     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000723     Document Type: Article

References (18)

1. McGuire JF, Ge NN and Dyson S: Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior. Am J Otolaryngol-Head Neck Med Surg 30: 121-133, 2009.
2. Martinez JC and Cook JL: High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: Is there a therapeutic role for elective neck dissection? Dermatol Surg 33: 410-420, 2007.
3. Weinberg AS, Ogle CA and Shim EK: Metastatic cutaneous squamous cell carcinoma: An update. Dermatol Surg 33: 885-899, 2007. (Pubitemid 47106729)
4. Trakatelli M, Ulrich C, Del Marmol V, Euvard S, Stockfleth E and Abeni D: Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: Accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 156: 1-7, 2007.
5. Alam M and Ratner D: Cutaneous squamous-cell carcinoma. N Engl J Med 344: 975-983, 2001.
6. Langer CJ: Targeted therapy in head and neck cancer: State of the art 2007 and review of clinical applications. Cancer 112: 2635-2645, 2008.
7. Argiris A, Karamouzis MV, Raben D and Ferris RL: Head and neck cancer. Lancet 371: 1695-1709, 2008.
8. Yang L, Wu S, Zhang Q, Liu F and Wu P: 23,24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and mitochondriadependent apoptosis in human breast cancer cells (Bcap37). Cancer Lett 256: 267-278, 2007.
9. Escandell JM, Kaler P, Recio MC, et al: Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: The role of p53 and p21. Biochem Pharmacol 76: 198-207, 2008.
10. Zhang M, Zhang H, Sun C, et al: Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B. Cancer Chemother Pharmacol 63: 635-642, 2009.
11. Chan KT, Li K, Liu SL, Chu KH, Toh M and Xie WD: Cucurbitacin B inhibits STAT3 and the Raf/Mek/Erk pathway in leukemia cell line K562. Cancer Lett 289: 46-52, 2009.
12. Liu T, Zhang M, Zhang H, Sun C and Deng Y: Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma. Eur Arch Oto-Rhino-Laryngol 265: 1225-1232, 2008.
13. Liu T, Zhang M, Zhang H, et al: Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer. Eur J Pharmacol 587: 78-84, 2008.
14. Thoennissen NH, Iwanski GB, Doan NB, et al: Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Res 69: 5876-5884, 2009.
15. Yin D, Wakimoto N, Xing H, et al: Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme. Int J Cancer 123: 1364-1375, 2008.
16. Haritunians T, Gueller S, Zhang L, et al: Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells. Leuk Res 32: 1366-1373, 2008.
17. Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D and Sebti SM: Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24: 3236-3245, 2005. (Pubitemid 40695105)
18. Wakimoto N, Yin D, O'Kelly J, et al: Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo. Cancer Sci 99: 1793-1797, 2008.